Cargando…
Oncolytic Adenovirus, a New Treatment Strategy for Prostate Cancer
Prostate cancer is the most common cancer and one of the leading causes of cancer mortality in males. Androgen-deprivation therapy (ADT) is an effective strategy to inhibit tumour growth at early stages. However, 10~50% of cases are estimated to progress to metastatic castration-resistant prostate c...
Autores principales: | Yang, Kaiyi, Feng, Shenghui, Luo, Zhijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775875/ https://www.ncbi.nlm.nih.gov/pubmed/36552019 http://dx.doi.org/10.3390/biomedicines10123262 |
Ejemplares similares
-
Oncolytic adenovirus-mediated therapy for prostate cancer
por: Sweeney, Katrina, et al.
Publicado: (2016) -
Oncolytic Adenoviruses in Cancer Treatment
por: Alemany, Ramon
Publicado: (2014) -
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
por: Uusi-Kerttula, Hanni, et al.
Publicado: (2015) -
Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity
por: Hajeri, Praveensingh B., et al.
Publicado: (2020) -
Oncolytic Adenoviruses in Gastrointestinal Cancers
por: Yokoda, Raquel T., et al.
Publicado: (2018)